Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

EYE vs AMSF

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EYE
National Vision Holdings, Inc.

Specialty Retail

Consumer CyclicalNASDAQ • US
Market Cap$1.81B
5Y Perf.-14.7%
AMSF
AMERISAFE, Inc.

Insurance - Specialty

Financial ServicesNASDAQ • US
Market Cap$569M
5Y Perf.-50.6%

EYE vs AMSF — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EYE logoEYE
AMSF logoAMSF
IndustrySpecialty RetailInsurance - Specialty
Market Cap$1.81B$569M
Revenue (TTM)$1.99B$325M
Net Income (TTM)$30M$46M
Gross Margin56.5%47.6%
Operating Margin3.0%17.8%
Forward P/E32.6x14.4x
Total Debt$695M$491K
Cash & Equiv.$39M$62M

EYE vs AMSFLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EYE
AMSF
StockMay 20May 26Return
National Vision Hol… (EYE)10085.3-14.7%
AMERISAFE, Inc. (AMSF)10049.4-50.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: EYE vs AMSF

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMSF leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. National Vision Holdings, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
EYE
National Vision Holdings, Inc.
The Income Pick

EYE is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 1.62
  • Rev growth 9.0%, EPS growth 202.8%, 3Y rev CAGR 6.5%
  • 9.0% revenue growth vs AMSF's 2.6%
Best for: income & stability and growth exposure
AMSF
AMERISAFE, Inc.
The Insurance Pick

AMSF carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 31.8% 10Y total return vs EYE's -18.0%
  • Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
  • Beta 0.23, yield 8.4%, current ratio 0.32x
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthEYE logoEYE9.0% revenue growth vs AMSF's 2.6%
ValueAMSF logoAMSFLower P/E (14.4x vs 32.6x)
Quality / MarginsAMSF logoAMSF14.3% margin vs EYE's 1.5%
Stability / SafetyAMSF logoAMSFBeta 0.23 vs EYE's 1.62, lower leverage
DividendsAMSF logoAMSF8.4% yield; the other pay no meaningful dividend
Momentum (1Y)EYE logoEYE+46.3% vs AMSF's -29.2%
Efficiency (ROA)AMSF logoAMSF5.6% ROA vs EYE's 1.5%, ROIC 21.9% vs 3.0%

EYE vs AMSF — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EYENational Vision Holdings, Inc.
FY 2025
Product Sales
44.7%$1.6B
Eyeglasses And Sunglasses
35.3%$1.3B
Services And Plans
10.7%$383M
Contact Lenses
9.0%$324M
Accessories And Other
0.3%$11M
AMSFAMERISAFE, Inc.

Segment breakdown not available.

EYE vs AMSF — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEYELAGGINGAMSF

Income & Cash Flow (Last 12 Months)

EYE leads this category, winning 4 of 6 comparable metrics.

EYE is the larger business by revenue, generating $2.0B annually — 6.1x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to EYE's 1.5%. On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
RevenueTrailing 12 months$2.0B$325M
EBITDAEarnings before interest/tax$153M$58M
Net IncomeAfter-tax profit$30M$46M
Free Cash FlowCash after capex$73M$8M
Gross MarginGross profit ÷ Revenue+56.5%+47.6%
Operating MarginEBIT ÷ Revenue+3.0%+17.8%
Net MarginNet income ÷ Revenue+1.5%+14.3%
FCF MarginFCF ÷ Revenue+3.7%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year+15.1%+10.3%
EPS Growth (YoY)Latest quarter vs prior year+111.3%-8.5%
EYE leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — EYE and AMSF each lead in 3 of 6 comparable metrics.

At 12.3x trailing earnings, AMSF trades at a 80% valuation discount to EYE's 61.7x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than EYE's 16.2x.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
Market CapShares × price$1.8B$569M
Enterprise ValueMkt cap + debt − cash$2.5B$508M
Trailing P/EPrice ÷ TTM EPS61.70x12.27x
Forward P/EPrice ÷ next-FY EPS est.32.60x14.42x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.20x8.53x
Price / SalesMarket cap ÷ Revenue0.91x1.80x
Price / BookPrice ÷ Book value/share2.12x2.30x
Price / FCFMarket cap ÷ FCF24.68x63.83x
Evenly matched — EYE and AMSF each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

AMSF leads this category, winning 7 of 7 comparable metrics.

AMSF delivers a 9.7% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $3 for EYE. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to EYE's 0.80x.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
ROE (TTM)Return on equity+3.5%+9.7%
ROA (TTM)Return on assets+1.5%+5.6%
ROICReturn on invested capital+3.0%+21.9%
ROCEReturn on capital employed+3.8%+16.8%
Piotroski ScoreFundamental quality 0–977
Debt / EquityFinancial leverage0.80x0.00x
Net DebtTotal debt minus cash$656M-$61M
Cash & Equiv.Liquid assets$39M$62M
Total DebtShort + long-term debt$695M$491,000
Interest CoverageEBIT ÷ Interest expense3.54x
AMSF leads this category, winning 7 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

EYE leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in AMSF five years ago would be worth $8,110 today (with dividends reinvested), compared to $4,462 for EYE. Over the past 12 months, EYE leads with a +46.3% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors EYE at 0.7% vs AMSF's -9.1% — a key indicator of consistent wealth creation.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
YTD ReturnYear-to-date-12.0%-18.3%
1-Year ReturnPast 12 months+46.3%-29.2%
3-Year ReturnCumulative with dividends+2.2%-24.8%
5-Year ReturnCumulative with dividends-55.4%-18.9%
10-Year ReturnCumulative with dividends-18.0%+31.8%
CAGR (3Y)Annualised 3-year return+0.7%-9.1%
EYE leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — EYE and AMSF each lead in 1 of 2 comparable metrics.

AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than EYE's 1.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EYE currently trades 76.0% from its 52-week high vs AMSF's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
Beta (5Y)Sensitivity to S&P 5001.62x0.23x
52-Week HighHighest price in past year$30.02$48.54
52-Week LowLowest price in past year$14.38$29.42
% of 52W HighCurrent price vs 52-week peak+76.0%+62.4%
RSI (14)Momentum oscillator 0–10040.834.2
Avg Volume (50D)Average daily shares traded1.4M212K
Evenly matched — EYE and AMSF each lead in 1 of 2 comparable metrics.

Analyst Outlook

EYE leads this category, winning 1 of 1 comparable metric.

Wall Street rates EYE as "Buy" and AMSF as "Buy". Consensus price targets imply 54.2% upside for EYE (target: $35) vs 46.9% for AMSF (target: $45). AMSF is the only dividend payer here at 8.41% yield — a key consideration for income-focused portfolios.

MetricEYE logoEYENational Vision H…AMSF logoAMSFAMERISAFE, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$35.20$44.50
# AnalystsCovering analysts146
Dividend YieldAnnual dividend ÷ price+8.4%
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS$2.55
Buyback YieldShare repurchases ÷ mkt cap+0.2%+2.1%
EYE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

EYE leads in 3 of 6 categories (Income & Cash Flow, Total Returns). AMSF leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallNational Vision Holdings, I… (EYE)Leads 3 of 6 categories
Loading custom metrics...

EYE vs AMSF: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is EYE or AMSF a better buy right now?

For growth investors, National Vision Holdings, Inc.

(EYE) is the stronger pick with 9. 0% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate National Vision Holdings, Inc. (EYE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EYE or AMSF?

On trailing P/E, AMERISAFE, Inc.

(AMSF) is the cheapest at 12. 3x versus National Vision Holdings, Inc. at 61. 7x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.

03

Which is the better long-term investment — EYE or AMSF?

Over the past 5 years, AMERISAFE, Inc.

(AMSF) delivered a total return of -18. 9%, compared to -55. 4% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: AMSF returned +31. 8% versus EYE's -18. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EYE or AMSF?

By beta (market sensitivity over 5 years), AMERISAFE, Inc.

(AMSF) is the lower-risk stock at 0. 23β versus National Vision Holdings, Inc. 's 1. 62β — meaning EYE is approximately 600% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 80% for National Vision Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — EYE or AMSF?

By revenue growth (latest reported year), National Vision Holdings, Inc.

(EYE) is pulling ahead at 9. 0% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to -14. 5% for AMERISAFE, Inc.. Over a 3-year CAGR, EYE leads at 6. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EYE or AMSF?

AMERISAFE, Inc.

(AMSF) is the more profitable company, earning 14. 9% net margin versus 1. 5% for National Vision Holdings, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 3. 1% for EYE. At the gross margin level — before operating expenses — EYE leads at 54. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EYE or AMSF more undervalued right now?

On forward earnings alone, AMERISAFE, Inc.

(AMSF) trades at 14. 4x forward P/E versus 32. 6x for National Vision Holdings, Inc. — 18. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 54. 2% to $35. 20.

08

Which pays a better dividend — EYE or AMSF?

In this comparison, AMSF (8.

4% yield) pays a dividend. EYE does not pay a meaningful dividend and should not be held primarily for income.

09

Is EYE or AMSF better for a retirement portfolio?

For long-horizon retirement investors, AMERISAFE, Inc.

(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). National Vision Holdings, Inc. (EYE) carries a higher beta of 1. 62 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMSF: +31. 8%, EYE: -18. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EYE and AMSF?

These companies operate in different sectors (EYE (Consumer Cyclical) and AMSF (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EYE is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock. AMSF pays a dividend while EYE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

EYE

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Gross Margin > 33%
Run This Screen
Stocks Like

AMSF

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EYE and AMSF on the metrics below

Revenue Growth>
%
(EYE: 15.1% · AMSF: 10.3%)
P/E Ratio<
x
(EYE: 61.7x · AMSF: 12.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.